259 related articles for article (PubMed ID: 27245594)
1. Preliminary study of a novel cognitive assessment device for the evaluation of HIV-associated neurocognitive impairment.
Anderson AM; Lennox JL; Nguyen ML; Waldrop-Valverde D; Tyor WR; Loring DW
J Neurovirol; 2016 Dec; 22(6):816-822. PubMed ID: 27245594
[TBL] [Abstract][Full Text] [Related]
2. Utility of a brief computerized battery to assess HIV-associated neurocognitive impairment in a resource-limited setting.
Yechoor N; Towe SL; Robertson KR; Westreich D; Nakasujja N; Meade CS
J Neurovirol; 2016 Dec; 22(6):808-815. PubMed ID: 27245592
[TBL] [Abstract][Full Text] [Related]
3. Specific amino acids in HIV-1 Vpr are significantly associated with differences in patient neurocognitive status.
Dampier W; Antell GC; Aiamkitsumrit B; Nonnemacher MR; Jacobson JM; Pirrone V; Zhong W; Kercher K; Passic S; Williams JW; James T; Devlin KN; Giovannetti T; Libon DJ; Szep Z; Ehrlich GD; Wigdahl B; Krebs FC
J Neurovirol; 2017 Feb; 23(1):113-124. PubMed ID: 27400931
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid interferon alpha levels correlate with neurocognitive impairment in ambulatory HIV-Infected individuals.
Anderson AM; Lennox JL; Mulligan MM; Loring DW; Zetterberg H; Blennow K; Kessing C; Koneru R; Easley K; Tyor WR
J Neurovirol; 2017 Feb; 23(1):106-112. PubMed ID: 27400930
[TBL] [Abstract][Full Text] [Related]
5. Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure.
Kamminga J; Bloch M; Vincent T; Carberry A; Brew BJ; Cysique LA
J Clin Exp Neuropsychol; 2017 Oct; 39(8):753-767. PubMed ID: 28052738
[TBL] [Abstract][Full Text] [Related]
6. Peripheral blood lymphocyte HIV DNA levels correlate with HIV associated neurocognitive disorders in Nigeria.
Jumare J; Sunshine S; Ahmed H; El-Kamary SS; Magder L; Hungerford L; Burdo T; Eyzaguirre LM; Umlauf A; Cherner M; Abimiku A; Charurat M; Li JZ; Blattner WA; Royal W
J Neurovirol; 2017 Jun; 23(3):474-482. PubMed ID: 28243867
[TBL] [Abstract][Full Text] [Related]
7. Neuropsychological Assessment of 412 HIV-Infected Individuals in São Paulo, Brazil.
Gascón MRP; Vidal JE; Mazzaro YM; Smid J; Marcusso RMN; Capitão CG; Coutinho EM; Benute GRG; De Lucia MCS; de Oliveira ACP
AIDS Patient Care STDS; 2018 Jan; 32(1):1-8. PubMed ID: 29323557
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of practice effect on neuropsychological measures among persons with and without HIV infection in northern India.
Ownby RL; Waldrop-Valverde D; Jones DL; Sharma S; Nehra R; Kumar AM; Prabhakar S; Acevedo A; Kumar M
J Neurovirol; 2017 Feb; 23(1):134-140. PubMed ID: 27739034
[TBL] [Abstract][Full Text] [Related]
9. Increased cell-free mitochondrial DNA is a marker of ongoing inflammation and better neurocognitive function in virologically suppressed HIV-infected individuals.
Pérez-Santiago J; De Oliveira MF; Var SR; Day TRC; Woods SP; Gianella S; Mehta SR
J Neurovirol; 2017 Apr; 23(2):283-289. PubMed ID: 27921220
[TBL] [Abstract][Full Text] [Related]
10. Screening for neurocognitive impairment in HIV-positive adults aged 50 years and older: Montreal Cognitive Assessment relates to self-reported and clinician-rated everyday functioning.
Fazeli PL; Casaletto KB; Paolillo E; Moore RC; Moore DJ; The Hnrp Group
J Clin Exp Neuropsychol; 2017 Nov; 39(9):842-853. PubMed ID: 28122474
[TBL] [Abstract][Full Text] [Related]
11. Cognitive reserve and neuropsychological functioning in older HIV-infected people.
Milanini B; Ciccarelli N; Fabbiani M; Limiti S; Grima P; Rossetti B; Visconti E; Tamburrini E; Cauda R; Di Giambenedetto S
J Neurovirol; 2016 Oct; 22(5):575-583. PubMed ID: 26965299
[TBL] [Abstract][Full Text] [Related]
12. Empiric neurocognitive performance profile discovery and interpretation in HIV infection.
Gomez D; Power C; Gill MJ; Koenig N; Vega R; Fujiwara E
J Neurovirol; 2019 Feb; 25(1):72-84. PubMed ID: 30519968
[TBL] [Abstract][Full Text] [Related]
13. The Repeatable Battery for the Assessment of Neuropsychological Status as a screening strategy for HIV-Associated Neurocognitive Disorders.
Costaggiu D; Pinna E; Serchisu L; Barcellona D; Piano P; Ortu F; Marongiu F; Mandas A
AIDS Care; 2021 Mar; 33(3):357-363. PubMed ID: 32183560
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of HIV-associated neurocognitive disorder (HAND) in Turkey and assessment of Addenbrooke's Cognitive Examination Revised (ACE-R) test as a screening tool.
Korten V; Ay U; Harı E; Tigen Tükenmez E; Gencer S; Akça Kalem S; Demirtaş Tatlıdede A; Gürvit İH
HIV Med; 2021 Jan; 22(1):60-66. PubMed ID: 32964651
[TBL] [Abstract][Full Text] [Related]
15. Neurological soft signs as a marker of cognitive impairment severity in people living with HIV.
Toro P; Ceballos ME; Pesenti J; Inostroza M; Valenzuela D; Henríquez F; Forno G; Herold C; Schröder J; Calderón J
Psychiatry Res; 2018 Aug; 266():138-142. PubMed ID: 29870954
[TBL] [Abstract][Full Text] [Related]
16. Peripheral blood lymphocyte proviral DNA predicts neurocognitive impairment in clade C HIV.
Ruhanya V; Jacobs GB; Nyandoro G; Paul RH; Joska JA; Seedat S; Glashoff RH; Engelbrecht S
J Neurovirol; 2020 Dec; 26(6):920-928. PubMed ID: 32737863
[TBL] [Abstract][Full Text] [Related]
17. Subtype associations with HIV-associated neurocognitive disorder in China.
Day TR; Smith DM; Heaton RK; Franklin D; Tilghman MW; Letendre S; Jin H; Wu Z; Shi C; Yu X; Pérez-Santiago J
J Neurovirol; 2016 Apr; 22(2):246-50. PubMed ID: 26306690
[TBL] [Abstract][Full Text] [Related]
18. A novel computerized functional assessment for human immunodeficiency virus-associated neurocognitive disorder.
Rosenthal LS; Skolasky RL; Moxley RT; Roosa HV; Selnes OA; Eschman A; McArthur JC; Sacktor N
J Neurovirol; 2013 Oct; 19(5):432-41. PubMed ID: 24081883
[TBL] [Abstract][Full Text] [Related]
19. A Screening Strategy for HIV-Associated Neurocognitive Disorders That Accurately Identifies Patients Requiring Neurological Review.
Bloch M; Kamminga J; Jayewardene A; Bailey M; Carberry A; Vincent T; Quan D; Maruff P; Brew B; Cysique LA
Clin Infect Dis; 2016 Sep; 63(5):687-693. PubMed ID: 27325690
[TBL] [Abstract][Full Text] [Related]
20. Neurocognitive Impairment in the Combined Antiretroviral Therapy Era in a Romanian Cohort of Young Adults with Chronic HIV Infection.
Temereanca A; Ene L; Rosca A; Diaconu CC; Luca A; Burlacu R; Radoi R; Bulacu-Talnariu A; Marcotte TD; Achim CL; Ruta S
AIDS Res Hum Retroviruses; 2020 May; 36(5):367-372. PubMed ID: 31476875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
